These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 34997957

  • 21. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ, Moliterno AR.
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [Abstract] [Full Text] [Related]

  • 22. Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy.
    Larsen CP, Wilson JD, Best-Rocha A, Beggs ML, Hennigar RA.
    Mod Pathol; 2018 Mar; 31(3):488-494. PubMed ID: 29148534
    [Abstract] [Full Text] [Related]

  • 23. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
    Nishi K, Sato M, Ogura M, Okutsu M, Ishikura K, Kamei K.
    BMC Nephrol; 2020 Aug 03; 21(1):323. PubMed ID: 32746791
    [Abstract] [Full Text] [Related]

  • 24. Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.
    Zhang Y, Kremsdorf RA, Sperati CJ, Henriksen KJ, Mori M, Goodfellow RX, Pitcher GR, Benson CL, Borsa NG, Taylor RP, Nester CM, Smith RJH.
    Kidney Int; 2020 Nov 03; 98(5):1265-1274. PubMed ID: 32540405
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome.
    Schönauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J.
    Front Genet; 2019 Nov 03; 10():465. PubMed ID: 31156713
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Atypical Presentation of Pregnancy-Related Hemolytic Uremic Syndrome.
    Baghli S, Abendroth C, Farooq U, Schaub JA.
    Am J Kidney Dis; 2018 Sep 03; 72(3):451-456. PubMed ID: 29331477
    [Abstract] [Full Text] [Related]

  • 33. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct 03; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 34. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
    Guzzo G, Kissling S, Pantaleo G, Pascual M, Sadallah S, Teta D.
    BMC Nephrol; 2021 Jul 06; 22(1):252. PubMed ID: 34229609
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
    Ferrer F, Roldão M, Figueiredo C, Lopes K.
    Nephron; 2022 Jul 06; 146(2):185-189. PubMed ID: 34724668
    [Abstract] [Full Text] [Related]

  • 37. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
    Bowen EE, Coward RJ.
    Am J Physiol Renal Physiol; 2018 Mar 01; 314(3):F454-F461. PubMed ID: 29167171
    [Abstract] [Full Text] [Related]

  • 38. Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
    Bogdał A, Badeński A, Pac M, Wójcicka A, Badeńska M, Didyk A, Trembecka-Dubel E, Dąbrowska-Leonik N, Walaszczyk M, Matysiak N, Morawiec-Knysak A, Szczepański T, Szczepańska M.
    Int J Mol Sci; 2021 Aug 31; 22(17):. PubMed ID: 34502390
    [Abstract] [Full Text] [Related]

  • 39. C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report.
    Wen J, Wang W, Xu F, Sun J, Chen J, Ni X.
    BMC Nephrol; 2018 Jun 25; 19(1):148. PubMed ID: 29940891
    [Abstract] [Full Text] [Related]

  • 40. C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.
    Chabannes M, Rabant M, El Sissy C, Dragon-Durey MA, Vieira Martins P, Meuleman MS, Karras A, Buob D, Bridoux F, Daugas E, Audard V, Caillard S, Olagne J, Kandel C, Ferlicot S, Philipponnet C, Crepin T, Thervet E, Ducloux D, Frémeaux-Bacchi V, Chauvet S.
    Am J Kidney Dis; 2023 Sep 25; 82(3):279-289. PubMed ID: 37061020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.